Cadrenal Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Cadrenal Therapeutics has a total shareholder equity of $4.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $5.5M and $1.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$5.04m |
| Equity | US$3.99m |
| Total liabilities | US$1.46m |
| Total assets | US$5.46m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: CVKD's short term assets ($5.4M) exceed its short term liabilities ($1.5M).
Long Term Liabilities: CVKD has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CVKD is debt free.
Reducing Debt: CVKD had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CVKD has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CVKD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 58.6% each year